BioSpace.com
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel

Status: 301 Moved Permanently Location: http://www.marketwire.com/press-release/Peregrine-Announces-Positive-Top-Line-Data-From-Randomized-Double-Blind-Bavituximab-NASDAQ-PPHM-1659434.htm